<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01314768</url>
  </required_header>
  <id_info>
    <org_study_id>BIMOH</org_study_id>
    <nct_id>NCT01314768</nct_id>
  </id_info>
  <brief_title>Brief Intervention for Medication Overuse Headache</brief_title>
  <acronym>BIMOH</acronym>
  <official_title>RCT of Structured Brief Intervention for Medication Overuse Headache Versus Business as Usual</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Akershus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Akershus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will perform a cluster randomised controlled study of Brief intervention
      (BI) for medication-overuse headache (MOH) versus business as usual. GPs will be trained to
      perform a structured brief intervention after identifying patients with probable MOH using
      the severity of dependence scale. The control arm will include patients of GPs who have not
      been trained in BI. Patients will be recruited by prior short postal screening of patients
      listed on the GPs patient lists.

      The hypothesis is that BI will lead to improvement of medication-overuse and chronic headache
      as compared to no BI.

      Main outcomes are:

        -  number of medication days per month

        -  number of headache days per month

        -  headache index
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      123 cases in all included (75 in intervention/placebo control arms and 48 in non-intervention
      Control arms) 19 did not meet predefined inclusion criteria for the different arms (5 and 8
      in intervention arm and placebo arm respectively, 4 and 2 in chronic headache Control and
      population Control respectively)

      1 case was lost to follow up in each of the 4 Groups prior to first assessment. Thus 60 cases
      remained in intervention/placebo Control arms (24 in intervention and 36 in placebo Control)
      and 40 in non intervention Control arms (15 chronic headache Controls, 25 population
      Controls).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of medication days per month</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of headache days per month</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion significantly improved</measure>
    <time_frame>3 month</time_frame>
    <description>proportion improved &gt;50% and &gt;25% in terms of no headache days/month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache medication days per month (diary reported)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache days/month (diary reported)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average headache intensity (VAS)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported health related costs</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term follow up of same outcomes as above plus relapse rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache index</measure>
    <time_frame>3 months</time_frame>
    <description>Headache intensity x frequency x duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow up of same outcomes as for 3 months</measure>
    <time_frame>6 months</time_frame>
    <description>Added extra time point due to cross over of non-treated patients into intervention Group if intervention was positive at 3 months.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Medication-overuse Headache</condition>
  <condition>Chronic Headache</condition>
  <arm_group>
    <arm_group_label>Brief intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Behavioural brief intervention delivered by GP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Business as usual</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Business as usual according to individual GP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic headache control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Screening and outcome control only. Non-intervention Control, screened and followed-up at final time point</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Population control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Screening and outcome control only. Non-intervention Control, screened and followed-up at final time point</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief intervention</intervention_name>
    <description>Structured behavioural Brief intervention given by trained GPs</description>
    <arm_group_label>Brief intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Business as usual</intervention_name>
    <description>GPs to treat patient as they have until now based on best established practice</description>
    <arm_group_label>Business as usual</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Screening and outcome evaluation only</intervention_name>
    <description>No additional intervention</description>
    <arm_group_label>Chronic headache control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Screening and outcome evaluation only</intervention_name>
    <description>No additional intervention</description>
    <arm_group_label>Population control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-50 years of age

          -  Screening positive for possible chronic headache (&gt; 10 headache days per month) (not
             for population control arm)

          -  Screening positive for possible medication-overuse (&gt; 15 medication days per month)
             (not for chronic headache control arm)

        Exclusion Criteria:

          -  Other complicating pain with medication treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christofer Lundqvist, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Akershus University Hospital and University of Oslo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Akershus University Hospital</name>
      <address>
        <city>LÃ¸renskog</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept of general medicine, University of Oslo</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2011</study_first_submitted>
  <study_first_submitted_qc>March 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2011</study_first_posted>
  <last_update_submitted>December 29, 2015</last_update_submitted>
  <last_update_submitted_qc>December 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Akershus</investigator_affiliation>
    <investigator_full_name>Christofer Lundqvist</investigator_full_name>
    <investigator_title>Principal investigator/Project leader</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Headache Disorders</mesh_term>
    <mesh_term>Headache Disorders, Secondary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

